StockData
Stimcell Energetics Inc. logo

Stimcell Energetics Inc. (STME) stock

STMEOTCSurgical & Medical Instruments & ApparatusFiscal year ends May 31
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày May 31, 2026Last filing: 10-Q on Oct 14, 2026Score 0/30
$0.16−0.07 (-29.57%)

Close on Oct 19, 2026Market cap $3.42MP/E –Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal , balances at Aug 31, 2026

Valuation

Market cap
$3.42M
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Fundamentals

Diluted shares
21M

Trading

Previous close
$0.23
Open
$0.20
Day's range
$0.16 – $0.20
Volume
867
Average volume (20 days)
2,890

Market cap history

Month-end market cap since 2013, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodSTMES&P 500DifferenceSTME per yearS&P 500 per year
1 month-26.4%+0.6%−27.0 pts
3 months-41.3%+3.4%−44.7 pts
Year to date-59.5%+13.3%−72.8 pts
1 year-64.0%+16.6%−80.6 pts
3 years+794.9%+86.4%+708.5 pts+107.6%+23.1%
5 years-14.7%+81.9%−96.6 pts-3.1%+12.7%
10 years-37.7%+318.9%−356.6 pts-4.6%+15.4%

Fifteen years at a glance

Fiscal years 2012 to 2026, USD

Revenue

–

Gross profit

–

Net income

–

EPS, diluted

–

Free cash flow

–
Reported period

Press releases

Releases Stimcell Energetics filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Stimcell Energetics

Surgical & Medical Instruments & Apparatus

Stimcell Energetics Inc. is a biotechnology company dedicated to the research, development, and commercialization of therapeutic and wellness products based on microcurrent technology. Its core proprietary offering is eBalance Technology, designed to deliver bioelectric micro amperage current to support cellular function, assist in general wellness, relieve pain, and help manage complications related to diseases such as diabetes, neuropathy, and high blood pressure. The company develops hardware solutions including the eBalance Pro System, intended for healthcare practitioners in clinical settings, and the eBalance Home System, engineered for direct in-home use by patients.

Company profile, executives and history

Stimcell Energetics stock: common questions

What is Stimcell Energetics's stock price?

STME closed at $0.16 on Oct 19, 2026, down 29.57% on the day.

What is Stimcell Energetics's market cap?

Stimcell Energetics was worth $3.42M at the close on Oct 19, 2026: the share price times the diluted shares outstanding.

Does Stimcell Energetics pay a dividend?

No. Stimcell Energetics has not paid a cash dividend over the last twelve months.

How has STME stock performed over the past year?

Including dividends, STME returned -64.0% over the past year, against +16.6% for the S&P 500.

Who are Stimcell Energetics's competitors?

Companies most similar to Stimcell Energetics by business, industry and size include EMED, BTCY, NUMD, TCMD, AMIX.

See a number that looks wrong?